LILLIAN IMPERANTE: Open Payments
NPI 1205015245 · MORRISTOWN, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,769 in 132 payments from 21 companies in 2025. Trend: 2023 $2,107 · 2024 $3,426 · 2025 $2,769
Food & beverage: $2,617Education: $152
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 31 | $405 |
| Janssen Biotech, Inc. | 12 | $289 |
| UCB, Inc. | 11 | $276 |
| E.R. Squibb & Sons, L.L.C. | 19 | $272 |
| Organon LLC | 9 | $244 |
| Galderma Laboratories, L.P. | 5 | $177 |
| GENZYME CORPORATION | 2 | $169 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 6 | $156 |
| Journey Medical Corporation | 1 | $122 |
| Lilly USA, LLC | 6 | $100 |
Products named: TREMFYA, Bimzelx, Sotyktu, DUPIXENT, VTAMA, SKYRIZI, NEMLUVIO, BOTOX.
Industry payments across NJ — which companies pay providers there.
